Bridgepoint Group plc (BPT) Earnings Call Transcript
March 14, 2024
Earnings Call Speaker Segments
Good morning, everyone, and welcome to the presentation of Bridgepoint's 2023 full year results. I'm William Jackson, founder and chairman of Bridgepoint, and with me this morning are Raoul Hughes, our CEO, and Adam Jones, our CFO. Before passing things to Raoul, I'd like to spend a minute on where the business stands as 2024 begins. The key message we have today is that Bridgepoint is in great shape. If you look back to our investor update in 2021, we were probably the first to say publicly, and very transparently I think, that more difficult times were starting in the alternatives market, and in particular that a slowdown was, that a slowdown was coming in the fundraise market. Today, our call is that this period is drawing to a close. We're seeing market conditions improve across all of our activities. But importantly, throughout that stretch since November 2021, Bridgepoint has kept raising, deploying, and realizing capital, while also carrying out our business development strategy. I think that demonstrates the strength of our model and how deep our platform is. As a result, on many measures today, we are now well ahead of where we expected to be at the time of our IPO in 2021.
There are two particular highlights from our 2023 that I want to call out. As you'll remember, in September we announced the combination with ECP. When that deal closes, Bridgepoint will give investors exposure to the three biggest and most significant strategies across private markets: private equity, infrastructure, and private credit. That comes at a moment when having a broad range of offerings really matters more and more, for both fund investors and shareholders, and — very importantly — our capacity to deliver high-quality operations across our platform from our group earnings. Second, BE VII. We've discussed BE VII for quite a while. We have long championed the resilience and the opportunity offered by the European middle market. That is in fact the foundation on which our business was constructed, and I'm happy to report that BE VII is on track to close at the end of this month, precisely at its target of EUR 7 billion. That's an excellent outcome. I'll now pass things to Raoul and Adam, who will walk you through the performance and progress in 2023, and following that, I'll wrap up with our outlook for 2024 and beyond. So, Raoul, over to you.
Thanks, William, and good morning, everyone. It's a pleasure to be presenting a strong set of financial results. Investment performance stayed robust in both private equity and credit. Crucially, deployment and fund returns each continued to track expectations. On fundraising, BE VII and ECP V remain on schedule, and we anticipate a solid year of capital raising ahead. Our balance sheet is in good shape and will get even stronger after a U.S. private placement, which we'll discuss in more detail shortly. The platform is well placed as activity picks up and the market readjusts. Now, as you'll have noticed, regarding ECP, we're awaiting the final regulatory clearance from the U.S. Energy Regulator, and we expect the deal to close in Q2 this year. If ECP had already been formally part of the group, closing AUM for the year would have come to EUR 62 billion, divided among private equity, infrastructure, and credit — 2.3x the IPO 32 months ago. Without ECP, our FRE margin rose from 31% to 36%, driven by higher management fees and disciplined cost control, which Adam will discuss further later. Adding ECP will produce a higher FRE margin than Bridgepoint standalone, factoring in the usual margin cycle, which peaks when new funds come on stream.
Turning to how our existing private equity and credit operations performed, management fees rose 10% to GBP 265 million, while underlying FRE climbed 28% to GBP 95 million. Given encouraging signals that the exit market is now recovering, we're glad to report PRE of GBP 55 million, which, though 15% lower year-on-year as we flagged back in September, still came in above what the market had expected. Consequently, underlying EBITDA was up 7% to GBP 149 million. I also thought it would be worth taking a quick look at how we've done over a somewhat longer horizon. From 2020 and the IPO onward, we will have increased AUM at an annual rate of 32%, ECP included, and on the existing Bridgepoint perimeter alone, fee income by 79% in total and PRE by 31%. By spreading our cost base across larger AUM and fee income, underlying FRE has nearly quadrupled and our FRE margin has more than doubled. We achieved all of that while expanding our investment team by only 9% and holding a consistent blended fee rate, with a small decrease stemming from the mix shift between private equity and credit. Importantly, we've been at this for a long time, and across the last 20 years, our strategy of pursuing growth both organically and inorganically has delivered AUM growth of 15% per annum.
Over the long term, through every cycle, this has been accomplished. Now, having covered the financial results, I want to spend the next few slides discussing what drives that performance in the business: fundraising, deployment and capital returns, and valuation progression. Even with a tough market backdrop, fundraising progressed well in 2023, with more than EUR 4.5 billion of capital raised across the firm and ECP. Together with fund performance, that gives us confidence we can hit our capital raising aspirations for 2024 and beyond. Credit had an especially strong year, with over EUR 1.5 billion raised for 2023 vintage funds, across Bridgepoint Direct Lending, Bridgepoint Credit Opportunities, and two more CLOs. That positions the credit business well to keep taking advantage of the more favorable interest rate environment. As William mentioned, near term, BE VII is expected to close this quarter at the EUR 7 billion target. ECP V is expected to close at the back end of April. We guided in September to a target of $4 billion, and we expect it will end up a bit ahead of this number. Both are great results in the current market and set up these funds with plenty of capital through their next cycles.
I want to give special thanks to William, who is seated beside me, from Bridgepoint's point of view, and also Doug Kimmelman at ECP, for their ongoing and untiring work, especially the global travel and investor meetings. During 2024, on the credit side, Bridgepoint Direct Lending IV, Bridgepoint Credit Opportunities V, two additional CLOs, and ECP ForeStar — the new ECP credit vehicle — will all be raising money. Meanwhile, in private equity, both BDC V and Bridgepoint Growth II will be in the market. Prospects for BDC V look especially strong, thanks to the exceptional results of BDC III, which ranks among the best-performing European low- and mid-market funds of its vintage. All of this activity rests on continued investment in our fundraising capabilities. The investor services team has more than doubled since 2021. We now have a global footprint, with new IR colleagues based in China, Singapore, South Korea, and Japan, plus dedicated coverage of the DACH region. That comes alongside a strengthened U.S. team and our first person focused solely on the private wealth channel. One beneficial result of the crowded fundraising market over the last two years has been the arrival of new LPs into BE VII, which has substantially broadened our geographic mix and drawn a number of new sovereign wealth funds to the platform.
Historically, Bridgepoint was overweight in the U.S. — the most mature LP market — which accounted for roughly 56% of BE IV's capital. Today our exposure is far more global, and the share of capital raised for BE VII coming from Asia and the Middle East has grown materially, reaching almost a quarter of that fund. That broader, more diversified investor base leaves us well placed for fundraising in 2024 and beyond. Turning to deployment pace — it is always lumpy. Our business has a certain seasonality in how processes begin and end, and following a strong H2 of fund deployment, especially in BE VII, we ended 2023 with all funds broadly on track versus their deployment targets. In BDC IV we may even be a deal ahead, at 79% invested. Importantly, our guidance on the timing of subsequent funds is unchanged. That is a strong endorsement of how our team approaches origination. The European private equity team, for instance, typically follows opportunities for an average of three years before investing, getting to know founders, families, and management teams very well. As a result, in our middle market, transactions often take place outside typical full auction processes and are therefore potentially less exposed to broader trends in M&A activity.
Although dealmaking activity was weak during 2023, we still handed back GBP 1.8 billion in capital to our investors, after selling six private equity holdings at an average return of 6.8x the money invested. What makes me especially happy is that a solid pipeline of possible exits is in place for 2024. Naturally, such matters are all-or-nothing and the timing is hard to predict, yet speaking here in mid-March, I feel confident about carrying on with delivery over the coming year. And last, fund performance. It stayed robust in both private equity and credit, and improving fund valuations drove the PRE figure we have announced today. Bridgepoint Europe VI stayed ahead of its plan, posting a MOIC of 1.8x, while BDC III demonstrated impressive momentum, climbing from 3x to 3.8x over the year. On the credit side, Bridgepoint Direct Lending III and Bridgepoint Credit Opportunities IV each stayed on plan, delivering net IRRs of 10.4% and 13.8% respectively. Within infrastructure, ECP III advanced nicely, its MOIC rising from 1.9x to 2x. Crucially, we keep booking exits above fund valuations, with an average uplift at exit across our private equity funds of 34% over the last five years — and in fact 48% for those exits made in 2023 — sustaining our robust record of top quartile DPI.
That fund performance strength—which tells us valuation progression keeps being recorded—doesn't happen by chance. It sits at the very heart of what this business does, and it's something we at Bridgepoint do extremely well. Xavier Robert, our Chief Investment Officer, went through this slide thoroughly at last year's interims, yet it bears repeating. Our investment approach is highly structured and disciplined. Clear asset selection plus our value creation toolkit form the core of our work, and they help us produce premium performance and valuation progression with no multiple expansion. The fund metrics on the right-hand side of this chart show exactly that: high growth, a high EBITDA margin, strong cash conversion, and leverage that is relatively low. In other words, growth businesses that perform strongly and are run sensibly. A great many of these, in fact, are mirrored in our credit business as well, where choosing sectors away from the more volatile ones, together with meaningful equity value cover, positions that business to fare well even when markets shift. Next, a few thoughts on ECP and the broader strategy before I pass things to Adam, who will take you through the numbers in greater detail. As I said, we expect the ECP transaction to close in quarter two.
Meanwhile, the teams across both businesses are investing considerable time working jointly. Preparation for global LP coverage is at an advanced stage. As a reminder, ECP adds more than 170 new LPs to the platform, with an attractively low overlap of roughly 20%. We have put mechanisms in place for sharing transaction opportunities after closing, and we expect critical functions to be integrated quickly, while product and strategy extensions will move into focus following closing. On ECP's performance, Fund V fundraising is progressing well and should close slightly ahead of target, as I have mentioned. Importantly, deployment stands on target at 40%, and with several interesting opportunities in the pipeline, that gives comfort that their fund cycle, too, remains on track. The more time we spend working together, the more excited I become about the future of the combined group. There is a genuine cultural fit between the two teams as we come to know one another better. Now, we intend to host a Capital Markets Day later in the year, including the chance to meet the wider ECP team, and I hope that many of you will be able to join us for it. ECP will represent an important step forward for the Bridgepoint Group, but I am conscious that we need to be prepared for further opportunities as the pace of consolidation in our industry keeps increasing.
With that in mind, we made the choice recently to refinance the existing ECP bond in part, after the ECP transaction closed, and to bring in additional capital via the U.S. private placement market. Those facilities depend on closing, and they'll restore balance sheet capacity so we can fund the next set of opportunities and investments in funds after the capital was used for the cash portion of the ECP deal. We're in a strong position to keep serving as a global leader in middle market added value investing, to build on that strong position, and to keep pursuing both organic and inorganic growth across investment strategies and geographies by scaling existing strategies, extending product strategy, and moving into new alternative asset classes while diversifying where our capital comes from. With that, I'll pass it to Adam, who will walk you through the numbers in more detail. Adam?
Thanks, Raoul. Good morning, everyone. I'll now walk you through some additional detail on how we performed financially in 2023 and bring you up to date on our guidance for 2024. On the whole, financial performance was very strong in 2023, supported by the strength and resilience of Bridgepoint's business, as Raoul has just described. Careful cost control and strong investment terms both contributed to today's results, and I'll say a bit more about each of those shortly. As you've heard, we've recently taken steps to further strengthen the balance sheet in support of our strategic growth plans, with an incremental $430 million private placement of debt. Today we are announcing a final dividend of GBP 0.044 per share, subject to approval at our next AGM. This means that our total capital distribution to shareholders in 2023, between dividends and share buyback, will be GBP 0.164 per share. That's more than twice the GBP 0.08 per share from 2022. Today we are setting out our guidance for FY 2024, and in summary, we are well placed to meet current market expectations. Let's start with assets under management. We raised a total of EUR 2.7 billion in Bridgepoint in 2023 across BE VII, Direct Lending III, and Credit Opportunities IV, and also delivered EUR 1.9 billion of realizations.
Gains in valuation tied to how strong and resilient our aggregate fund performance has been contributed another EUR 1.7 billion. Those uplifts in valuation came from trading, with weighted average EBITDA growth of 19% across our private equity funds, versus -5% for the MSCI European Index. Importantly, 81% of our unrealized valuation multiples were either flat or reduced in the year, and that really underscores how strong earnings performance has been within our portfolio. As a result, AUM ended 7% ahead of the prior year at EUR 40.5 billion. If we adjusted those figures for the addition of ECP, assuming the transaction had closed in 2023, total group AUM would have grown by 62% to EUR 61.6 billion. Now, turning to fee-paying AUM, we raised a further EUR 1.4 billion of capital commitments and deployed EUR 2 billion of new fee-paying capital. Against this, fee-paying asset realizations from both the sale of equity investments and the return of capital on credit strategies total EUR 0.8 billion. So in total, our fee-paying AUM grew by 11% year-over-year. Again, with the addition of ECP, fee-paying AUM would have grown by 57% to EUR 36.7 billion. This growth in fee-paying AUM obviously delivered strong growth in management fees and other income, which grew by 10% to just over GBP 266 million in the year, including catch-up fees of GBP 6.7 million for BE VII.
Overall, revenues rose 5% compared with a year earlier, reaching just under GBP 322 million. Across every one of our strategies, fee margins held steady in 2023; the modest decline versus the prior year came from private credit making up a larger share of our fee-paying AUM. As we had already indicated at the 2023 interim results, PRE was heavily weighted toward the second half and accounted for 17% of total revenues, and the assets we decided to sell produced an average 6.8x money multiple. That outcome came in a little above our earlier guidance of 15%, reflecting how strongly our funds traded over the last six months. PRE, as you know, does not arrive evenly through the year — it hinges on how fund performance develops and on when exits occur. We do anticipate that PRE for 2024 will carry a similar second-half weighting this year. Before moving on, I want to flag the substantial potential future value sitting in our fund co-investments in carried interest, which together will drive PRE in the years ahead. We have recognized close to GBP 300 million of PRE since 2018, yet the embedded potential value of future PRE is still very material: more than GBP 1 billion is expected from current funds, including those materially raised to date.
Okay, let's unpack that into its individual components so I can show you what I mean more clearly. On the right-hand side of the page, in the graph's second bar, you'll notice GBP 67 billion of carry remains to be recognized from current funds, assuming those funds are fully realized at their Q4 2023 valuations. After that, roughly GBP 400 million of PRE stands to be earned from fully invested funds, provided they hit their target returns. And lastly, illustratively, there's nearly GBP 700 million more in PRE from funds that aren't yet fully invested, should those two ultimately achieve their targeted returns. When you look at how the graph splits carry versus co-invest, it's clear that moving from the left side to the right side, carry within PRE grows materially, which plainly mirrors the fact that newer funds carry a higher corporate share of carried interest. Now let's turn to operating expenses. For the year, those came to GBP 171 million, up just 1.6% from 2022. Careful cost control contributed importantly to overall performance this year, through prudent management of cost growth and headcount investment amid what was an uncertain macro environment.
When you look at total personnel costs, they were basically unchanged compared with a year earlier. Headcount investments were mostly phased across the final six months, and that was offset by a lower bonus expense, reflecting fewer exits that we realized during the year. FTE growth of 3.7% in 2023 came mainly from continued investment in portfolio support teams, investor relations, and our credit team. Other expenses rose 7% to just over GBP 45 million, largely due to increased travel and higher legal and regulatory spend, along with completion of our AIFM registration in Luxembourg. Now that we've reviewed revenue and expenses separately, let's turn to the impact on group profitability. Fee-related earnings increased 28% to GBP 95 million in 2023, reflecting the first full year of fees on BE VII, together with the cost control efforts I mentioned. Our FRE margin kept expanding, hitting 36%, which is now more than double what it was since the IPO. With FRE and resilient PRE combined, underlying EBITDA reached almost GBP 149 million, a 7% improvement on 2022. Turning to the reconciliation between underlying and reported profit before tax, that is driven by obviously exceptional expenses, which this year consist principally of expenses incurred in the combination with ECP.
Turning to the tax charge for a moment — it went up from GBP 6.8 million in 2022 to a little more than GBP 50 million in 2023. As for the underlying effective tax rate, it rose to 11.4%, and the reason is that we had fewer completed fund exits than in the prior year. Next, a high-level summary of the underlying Bridgepoint balance sheet, which leaves out the presentational effect of consolidating our CLOs, because, as I said earlier, that accounting requirement does tend to muddy the underlying position somewhat. The private placement we recently completed comes to $430 million, spanning a mix of three-, five-, seven- and 10-year tenors, at a blended coupon of slightly above 6.17%. The extra funds raised will sit on deposit earning roughly 5%, so until they are deployed they will have only a marginal effect on our expense line — the interest expense line, obviously — and once deployed, they will begin producing incremental profits and cash for the group. This gives us considerable new capacity to back our business development strategy, and in fact it fully replenishes the liquidity we had after the IPO. Adding together the GBP 239 million of cash and the undrawn GBP 250 million revolver, we had liquid resources at the year-end of almost GBP 500 million, versus a cash funding obligation of a bit more than GBP 230 million on completion of ECP.
On the balance sheet, co-investments still account for merely 1.3% of total AUM, which once more highlights how capital light our profile is. As you're aware, we finished our initial GBP 50 million pound share buyback program in October, and after that we started a second GBP 50 million pound share buyback, which still had GBP 40 million pound left to deploy at year-end. Combining that proposed dividend with the share buyback, our total capital distribution to shareholders this year comes to GBP 0.164 per share. Now, to wrap up my portion of the presentation, I'd like to move on to guidance for 2024. In summary, as I mentioned, we feel we are well-positioned to meet the market's current expectations for this year. To keep things simple, from now on we will present and guide the underlying performance of the group, assuming a full year of the combined group of both Bridgepoint and ECP. Apart from the fact that ECP V is now aiming to close slightly ahead of its $4 billion target, we are today reiterating the guidance we provided in September regarding ECP. When it comes to fundraising, we expect the group to raise a minimum of EUR 20 billion over the next fundraising cycle.
For Direct Lending IV, we anticipate fees beginning to come through during the latter six months of 2024. Bridgepoint Development Capital V and Credit Opportunities V should start in the first half of 2025, while ECP Fund VI follows in the second half of that same year. As Raoul and William mentioned, BE VII is projected to reach its EUR 7 billion target and close within the current quarter, and since roughly 10% of fund commitments will actually finish in 2024, catch-up fees should land at approximately GBP 12 million for this year. On the credit side, we anticipate putting to work about EUR 1 billion in net fee-paying AUM annually across each of the coming three years. Just like 2023, PRE will be significantly skewed toward the back half of this year — roughly 2/3 of the four-year total, let's say. For this year, we look for PRE to land at the top end of our customary 20% to 25% of total income range. Once you strip out the ECP effect, 2024 total costs will probably show high single-digit compound growth versus 2022, since inflation is still with us. Exits should accelerate, bringing a matching rise in the bonus pool, and the timing of 2023 hires along with postponed recruitment will weigh on the full-year cost base for 2024.
So because of that, our near-term guidance for FRE margin is still the same, staying in the low- to mid-30% range until BE VIII begins generating fees in 2026. That's a modest decrease from the 36% margin we achieved in 2023, but it's fully expected and simply mirrors the normal margin pattern of the private equity cycle, in which fee-paying AUM will now naturally contract in 2024 as we begin to successfully realize investments ahead of the next significant fundraise. But importantly, our long-term FRE margin guidance of 45% and above is still unchanged. Lastly, we now expect the effective tax rate for the enlarged group to be approximately 15%. The Bridgepoint element hasn't changed. The rise just reflects the effect of ECP's profits at U.S. federal tax rates. With that, I'll pass it back to William for closing remarks.
Thank you, Adam. We've gone through quite a bit of ground this morning, but to wrap up, looking back at 2023, we kept delivering really meaningful progress on the strategy we laid out at the IPO, as I mentioned earlier. Investment performance remains solid in both private equity and credit. Importantly, fund deployment and fund returns are both still strong and tracking to plan. On fundraising, we and ECP are on course to wrap up our flagship fundraisings at or a bit above target. The balance sheet is in good shape. It has been replenished and recapitalized. All of this supports the strong financial performance in 2023 and the 2024 outlook Adam just described. Going forward, I'd say our industry outlook is getting more and more positive following the pause of recent years. We've entered 2024 with a genuinely healthy pipeline for investments and exits. We can keep investing in our people and platform. That matters a great deal. We're still pursuing growth opportunities, both organic and inorganic. And I think we're very well placed to gain from and lead further industry consolidation. To sum up, the platform is well positioned as activity speeds up and recalibrates in the alternatives market. So now I'd like to turn things back to Paulie, our operator, who will handle the Q&A process.
Over to you again, Paulie.
Thank you. At this point, ladies and gentlemen, we're going to move into the question and answer portion. We'll take questions from the phone line first, and after that we'll get to questions that came in through the webcast page. Just a reminder that participants can send in written questions by clicking the Ask a Question button on the webcast page. If you'd like to ask a question over the phone, hit star one on your keypad to raise your hand and get into the queue. When you're called on to ask your question and you happen to be listening to the conference through your device's loudspeaker, please pick up your handset so that your question comes through clearly. Once more, that's star one on your phone keypad. And your first question is from Arnaud Giblat at BNP Paribas Exane. Your line is open.
Morning, and thanks — I have three questions. First, on the fundraising for BDC V: what other parameters are you considering when thinking about how to size that fund? Given that BDC IV now sits at a 3.8x money multiple, I'd assume demand would be pretty strong, so I'm curious how you're approaching the sizing and whether there are any constraints. My second question ties to that: with BDC IV at 79%, how many additional deals do you need there before BDC V gets activated? Third, on the headroom you've built on the balance sheet — the $430 million placing. Much of the M&A you've completed, and the ECP transaction, involved a significant proportion in equity. Clearly you've rebuilt the capacity to do M&A. Is that something you could envision? Could you be opportunistic if something does present itself, or will you first focus on integrating ECP? Thank you.
All right. Thanks, Arnaud. Good morning to you. I'll hand those over to Raoul.
Morning, Arnaud. BDC V. So the one sitting at 3.8x is BDC III. It's the kind of... That's the fund before last, the one that really drives how the fund performs. The fund right before the current one is what really drives your performance, so to speak, and your fundraising next time around. For BDC V, our target fund size is EUR 2 billion, and we're in the market right now. The best thing to say about that is we want to be cautious about individual fund-raising amounts as we move forward into the next phase of our growth. So the target fund size for BDC V is EUR 2 billion. As I think I said in my part of the talk, we're pretty confident in that fundraising, given how the business has performed. I think it's also one of the things we're very disciplined about — making sure we raise the right amount of capital for any one of our strategies, so that we can keep investing it well through a sensible kind of timeframe through the next fundraising cycle. So we're not. We clearly want to grow the business, we want to raise more capital.
We want to accomplish that in a highly disciplined manner and secure the appropriate amount of capital for every strategy.
Also, Arnaud, another point: since that fund is likely the best performer among its peers, it should give us a solid opportunity to shape who its investors are over the coming decade—
Right.
... given how much demand we’re seeing for that program.
So EUR 2 billion is what's shown on the cover. We're going to stay disciplined on that. Regarding where BDC IV stands, I suppose in the end they put money into equity-sized deals across a fairly broad range. My expectation is that it probably takes three or four deals to get them across the line. It hinges heavily on what they actually end up doing, you know, deal by deal, but three or four, roughly that count. Then, on M&A, I'd say the USPP has restored us to the same liquidity position we held at the time of the IPO. So we've essentially swapped out the cash portion of the ECP transaction, which is a number broadly similar to the primary capital we raised at IPO, and that puts us back in the same position to keep growing the firm through various forms of M&A. I think you're absolutely right, and the transactions we pursue will likely include fairly significant share components. The main reason is that I'd expect the deals we do to be with independent firms, where founders are looking to come aboard the platform. As part of that, we want them tied in through equity, and they want that too, and that's one of the great advantages of our position as a listed business; we're able to offer this.
I think you could look at it as that amount of cash representing a minority share of any larger deal we might pursue. So we believe we're in a strong position to keep building the firm and to grow through M&A. But obviously, everything depends on finding the right opportunities at the right moment with the right people. Cultural fit, as we mentioned regarding ECP, cultural fit with this business matters enormously. We are very much a people business. With any deal we pursue, we need to partner with like-minded people who we believe can add to the broader platform and the culture of the firm.
So really, it's just — you know, we've got the capacity for an ECP-
ECP.
Also for phase II, I should add. Still, I wouldn't anticipate that showing up in the near future. As ECP has demonstrated, we'd take a very careful and prudent approach to identifying the right opportunity. Does that address what you asked, Arnaud?
Yes, that's excellent. Thanks a lot.
Thanks. Paulie, I’ll hand it back to you for the following question.
Alright, next up. Our next question is from Nicholas Herman at Citi. Go ahead, please.
Yes, thanks. Good morning, and thank you for the presentation. Good morning — I have three questions. First, to follow up on growth: beyond inorganic growth, I believe you also mentioned deploying the incremental capital from the private placement to speed up organic growth too. Could you give us more detail on what you mean by that? Are you referring to building out lateral strategies at Bridgepoint and ECP, or ECP, regional expansion, and so forth? More detail there would be much appreciated, much appreciated. Second, on exits, could you please elaborate a bit more on what sits behind the guidance? How many exits do you have in process or expect to commence, and how many exits underpin your guidance? And as part of that, do the buyers of your assets tend to be more biased toward sponsors or strategic buyers? Then the final question, please. Regarding... I guess you spoke about healthy pipelines and health. I think the update on deployment can be found. So can you be a bit more specific about which funds...
Okay, apologies. So I suppose my question is how you're viewing where we are in the fund cycles right now across the different strategies. That's what I'm asking. Yeah.
Alright, Raoul, would you like to handle the first question?
Sure — so it's about speeding up our organic growth. I think that comes from deepening the strategies already in place in the markets they operate in, plus pushing into broader geographic regions. We'll keep growing and extending the private equity business across the mid-market verticals where we're active, and I'd expect we'll go a bit further geographically as well. With ECP, we genuinely believe there's a real chance to grow ECP's business into Europe. A big part of what drew us to the deal was the network and contact base we hold in continental Europe, which gives them a chance to put capital to work there — something they haven't done previously. And when you consider the entire energy transition market, which is a really hot space right now, and you look at the Inflation Reduction Act in the States, there's plenty of talk about something similar taking shape in Europe. The new Labour government in the U.K. is making similar noises — or the potential new Labour government, rather. So I think there's a genuine opportunity for energy transition in Europe, and I think the platform we now have in the U.S.
ECP is going to add to our broader equity business in the States. I think there's… we genuinely believe there's a real opportunity — there's a need and a real opportunity to scale our credit platform, both in Europe and outside Europe. And I think credit is one of the… it's a product, a product class that we should be able to scale organically very quickly. So that's probably a slightly waffly answer.
Should I handle the exits?
Yeah, well, yeah. Take it.
I mean, look, when it comes to exits, everything really comes down to how you manage the portfolio across the various funds. So we've positioned ourselves to maintain vintage year discipline, both when it comes to new investment and when it comes to exits. So we're making an effort not to specifically time the macro. The character of the assets we hold makes that easier for us. So at any given moment, we probably have 20%, 25% of the portfolio that could potentially be exited, and as we begin the year, we look at how much capital we want to return in order to drive fund performance. Our focus is on net IRR, total value, and how much capital we've returned to investors — the DPI metric — and we want to be sure we've got optionality. So, you know, at the end of the day, these are individual events, and as Raoul has said many times, they either happen-
Either they do, or they don't.
Exits either occur or they don't. Even so, for the target we're aiming to deliver, we typically keep twice as many exits in our sights. That gives us reasonable confidence about it.
And that applies to all of the equity businesses.
Yeah, yeah.
Yes, to some extent—and among those 23 exits, it turned out that a greater share came from the growth side and the BDC side of the business rather than from the BE side. But we, so we look across... And you made a brief remark about the different fund side. We are examining exits throughout all of our private equity businesses.
And yeah, regarding deployment, we've got a solid pipeline in place. Deployment just doesn't really move in a straight-line fashion.
Yeah.
It's a bit like buses, isn't it? Two or three show up at once. Our Q4 in BE was extremely active. The pipeline there has been rebuilt nicely. BDCs-
Same here.
And it's the same thing, right, Raoul?
The private equity business has a genuine seasonal pattern to it—
Mm.
You usually see deals kicked off at the beginning of each half-year, and after that, folks try to hit their goals for completions and signings ahead of big holidays and breaks. So what tends to happen is you might spend a good stretch of time working on transactions, yet they typically close either right before Easter, or right before the summer, or right before Christmas or Thanksgiving in the States. It's a process with a seasonal pattern, in a way.
If you look at the equity funds — which I suppose is the area drawing a lot of attention — you're at times ahead of the curve and at other times slightly behind it. And if you look at BDC, as Raoul mentioned—
It's ahead.
It's ahead of the game, which is nice. BE VII is actually at exactly the same point that BE VI was at this same time.
The exact same figure, at the identical point in time.
And that was put in across 3.5 to 4 years, and we would anticipate the same.
Remain unchanged.
Yeah.
ECP follows the same pattern. If anything, theirs is a bit more uneven than ours. A typical Bridgepoint private equity fund holds 16 to 20 deals. ECP therefore runs a more concentrated strategy, which means they might carry 10 to 12, and so naturally their deployment is lumpier as well.
Nicholas, I hope that addresses what you asked, and we will—
Yeah.
We’ll hand it back to Paulie for the following one.
Could I just ask a quick follow-up on that?
Yeah.
Apologies, yes — I simply wanted to revisit the subject of who might acquire your assets.
Oh, yeah.
Between—
Right.
And that split between sponsor and strategic — I'm asking because a peer you list had said earlier that it now sees potential purchasers of its assets growing less inclined to complete deals, since those buyers don't want to put money to work in today's difficult climate and then have to return to their own LPs for additional capital. So I wanted to check whether that's something you're also observing?
Nope.
And sort of, are you exposed to that?
Not a problem whatsoever. In fact, right now we've just been through a good number of processes involving strategics, and it's always nice to see strategics returning. As we've mentioned previously, folks feel more at ease doing a EUR 1 billion or EUR 1.5 billion acquisition today than one at EUR 10 billion. That suits us perfectly. Looking at the large buyout market, something that brings a smile to Raoul's face and mine is witnessing the enormous amount of capital parked there, ready to be put to work, while we hold the store containing all the assets. So come on down.
That's quite useful. All right, many thanks.
Paulie, please come back. All right, I’ll hand things over to you for the following question.
Appreciate it. Our following question is from David McCann at Numis. Your line is open.
Morning, David. It's nice to see you as well.
Morning, everyone. Yeah, same to you. Quite often as well, unfortunately. So first, on consolidation, we've been in touch a couple of times on this. You've talked before about real estate being an obvious private asset that you clearly don't hold right now and perhaps a gap in the portfolio, but there's obviously been dislocation in that market over recent years, shall we say. So would that still be the obvious gap when you're considering your own potential future M&A plans, yeah, expansion into other areas, maybe building up some of the existing capabilities in adjacent areas? How do you think about that first question? Second, on the timing of BE VIII and the next ECP funds, I appreciate it might be slightly premature to ask about this, but, I mean, any color on timings around that sort of 2026, 2027, something else, some, yeah, just some color on what your expectations would be, given the current state of the market in total, would be helpful. And then finally, a slightly more technical one on, yeah, the carry receivable accruals are noticeably increased in the second half, I think that was touched on in the presentation as well. Maybe just talk through some of the mechanics of what's driven that increase.
How much of that comes from how active the period was, how much is tied to marking to market, and how much reflects the expected pipeline, I guess, moving a bit nearer to fruition? And really, what other big drivers pushed those numbers up so notably in the second half? Thank you.
Fine, the first couple go to Raoul, and number three goes to Adam. Raoul.
Right. So if you take the traditional verticals within alternatives, real estate — your point is fair. The portfolio does lack exposure to that real estate vertical. Whether it's the right move for us will really hinge on how we see that market developing and whether we can find the right entry point at the right moment alongside the right partner. So I wouldn't rule it out, but I also wouldn't call it the most advanced piece of our thinking. There's plenty of room to grow within the verticals we already have. And another area is the secondary world — how we think about the right way to play there as it evolves and splits somewhat between LP secondaries and GP-led secondaries, and how we enter that segment of the market. So, wouldn't rule it out, but it really comes down to whether you can find the right partner firm, in terms of scale, location, and cultural fit.
To pick up on what you mentioned before, the organic-
Yeah.
So in Europe, the mix of organic growth plus M&A together with ECP is genuinely compelling.
Yes, that's true. I believe that's another way of viewing it. There are numerous ways for us to achieve the growth aspirations we hold without needing to complete a real estate transaction.
Yeah.
That’s the right way to think about it, instead of ruling it out.
What's the timing for the next generation of funds?
Well, that's likely everything for you, isn't it?
Well, we're just about done with the final batch. As we know, so—
I mean, just look at him. He has aged a tremendous amount over the last… I mean, looking at this, after having gone around—
Thanks a lot.
... as far as increasing the size of the fund we already have, I think we'd kind of prefer to take a bit of a breather-
No, but we — I mean, I suppose the response is the one that follows. David, those funds' timing hasn't changed at all. My expectation isn't that fundraising market conditions will get dramatically better over the coming few years. You know, you've got the pigs moving through the python when it comes to portfolio size and returning cash to investors, and that will make a big difference. Still, you know, our LP base is now quite diversified.
I believe that's-
And like Raoul mentioned before, having those new LPs from ECP on board really adds breadth, which is great. We feel quite confident that we're in a strong position for the next time around, and it will happen on the schedule that Adam laid out. Carry, Adam?
Sure. Good morning, David. When you examine PRE for 2023, the trajectory was very strongly powered by BE VI, especially BDC III, along with the expansion we saw from BG I. BDC III and BG I were specifically the places where we focused our exits and achieved meaningful fund advancement. More importantly, though, both of them made substantial headway on fund performance by fully returning their preferred return to investors, which locked in the carry hurdle and, as a result, considerably lowered the fund's risk — that then lets us clearly capture a larger portion of that carry component. Still, as I mentioned, looking ahead, if you consider the amount of inherent PRE that remains tied up, there's a lot more value still to be realized across roughly the coming 4 to 5 years.
That progress at BDC III has really driven things forward—
Yeah.
That's a significant improvement.
Definitely.
Honestly.
Yes. In BDC III, the corporate carry is fairly high compared with our other historical funds, and the fund is doing very well. Once you reach roughly 3.8x your money in current value—and we expect it to be accompanying all of that at the end—the carry opportunity is tremendous, and it's really coming through in the valuations. And I think it's an interesting… PRE is an interesting part of the business in that, you know, we've talked a lot this morning about how lumpy exits are, and it really isn't linear. The way we really look at it internally, I guess, is twofold. From a fund management perspective, as William says, we're constantly looking at which of our assets—which of the 25% on average of our assets—we want to try and exit. What's the constantly working proactively to think about how do we exit businesses and what's the right timing and money back? And then from a sort of a management company impact and fund perspective, we really look at the total embedded value of that investment. And then, the chart that Adam showed, there's a significant embedded value at on the balance sheet of the current value of our funds.
Yet a great deal of value is going to come through across the coming 5 years as the funds we already have mature, perform better, and produce their returns. On top of that, as time passes, a larger share of corporate carry sits within the management company for both the newer funds and the older ones. So that is really going to turbocharge things going forward. So even though you folks generally don't value PRE as highly as FRE, within this business — despite the fact that we run a somewhat asset-light model — the assets we do hold and have invested in our funds are positioned to generate substantial profit and cash across the next couple of fund cycles. All as the carry flows in, the funds deliver, and that bigger share of corporate carry gets realized.
David, do you have any follow-up questions based on that?
No, that's great. Thanks a lot for all of that. Really helpful.
Paulie, over to you.
Just before we move on to the following question, here's a brief reminder. Should you wish to pose a question over the phone, kindly press star one on your keypad. Our next question is from Angeliki Bairaktari of JPMorgan. Your line is open.
Good morning, and thanks for taking my questions. I have a couple of quick follow-ups, please. Coming back to the carry question that was just asked: within the GBP 55 million PRE you had in 2023, could you tell us how much of that actually reflects exits versus how much is just value, just so we have an idea? And my second question: on slide eight, I can see that Bridgepoint Credit Opportunities IV is now 85% deployed. So does that mean we could expect the next vintage of that strategy to be activated in 2024? And lastly, if you could also speak to the target size you have on BDL IV, please. Sorry — BDL V. Thank you.
Alright, Adam, would you like to take the PRE point?
Okay, hi Angeliki. So if we look at how that 2023 PRE figure of 55 million splits apart, you get GBP 30 million coming from carry and GBP 25 million from co-invest. And just to be clear, co-invest is basically the share of value gains on the GP co-investments sitting on our balance sheet, marked to market in a plain way according to the fund elements. Carry, of course, is then shaped by the exits as well as the discount unwind, and that, as I mentioned, was concentrated in BDC III and BG I.
Alright, Raoul, let's turn to the credit funds.
Yeah, I mean, out of those two, the direct lending fund is what we're concentrating on for the first half of the year. When you consider the scale and the size of direct lending, you have to view it as a whole for the vintage. What we're seeing in that market is a blend, as we've talked about previously, a blend of investors putting money into the fund itself and investors putting money into dedicated SMAs sitting alongside it. So you have to consider that as a whole, because the blend between those two could very well change. The overall target is roughly GBP 4 billion across all of them. Well, I don't... I believe that will be raised over the course of 2024 and 2025. And bear in mind, in credit, the fee base here works differently than in equity, where the fee base depends on the deployed capital as you deploy it. So the key metric in credit is making sure your fundraising stays ahead of your deployment pace. And as a result, you always have somewhat more capital to deploy than you are deploying, and that ensures you can stay in the market.
So even though that's roughly the figure overall, we anticipate increasing it across 2024 and 2025 — and that isn't something you require with certainty. To get started, there's no need to bring in the $4 billion. You bring it in gradually, and you put it to work as you proceed.
When does the shift from four to five happen—when are you expecting that?
Well, I'd say in credit it's more a question of timing for the shift rather than, sort of—
Got it.
Because basically, once the capital is closed, you simply begin putting that capital to work—
Alright.
...into separate pieces. It's not, it's not the same kind of-
So, you can—
Cliff, whenever you’re ready—
So would you put the two of them together in that sense?
Sure, that's something you could do if you'd like.
Alright.
You simply distribute it in a different way across the various pools.
Angeliki, does that clear up those questions you had?
Yeah, regarding the BCO IV — sorry, I mean the BCO V then — that's the same kind of interplay, I suppose, in which—
Correct.
... since the fund right now sits at 85% deployed-
Yes.
So that fund is basically tapped out, which doesn't leave you much more firepower to deploy from it. My assumption is that you've already raised some capital for BCO V-
Nope.
So where could you potentially begin putting money to work?
Yes.
Yeah, but another thing about the Credit Opportunities Fund is that it tends to move a bit faster, since a good deal of the capital they put to work comes back pretty quickly, given the kind of work they do. So right now it's deployed-
Okay.
... reaching roughly that level.
And you’re able to put that back to work—
Yes, that's right.
... potentially?
Yeah. Yeah, you've got it. It's not — again, it isn't really the same kind of setup as having a private equity fund. You can actually sort of deploy—
Correct.
Within the investment window, it’s about how you put capital to work. It really hinges on the mix of deployment, deployment, and how quickly repayments come back. In a direct lending strategy at least, there is a component where these factors tend to align — when you’re putting more money out, you often receive more back because exit markets are healthier. And when deployment slows a little, the assets you hold become somewhat stickier. Credit opportunities involves more of, I’d say, entering and spotting openings, purchasing positions, and then trading around them a bit more. But the way you… The way I’d frame it is what sustains the deployment, and that total deployment amount, gradually increasing over time.
That figure is net deployment.
That figure is net. And as you consider the guidance Adam provided, it's, we are—
The figure comes in at roughly 25.
…we're giving guidance of roughly GBP 1 billion annually—
Yeah.
... along with an additional net rise in the capital that has been deployed toward credit.
Alright.
That's fair, but if I could just — sorry, one more point. So on BCO, for modeling purposes, is it reasonable to assume the next vintage begins deploying in 2025 rather than 2024?
Yes.
Yes, but yes.
Thanks.
All right, Paulie, let’s take the next question, assuming there is one.
That brings us to the end of questions from the phone lines. Next, we'll take up the questions that came in through the webcast page. Adam Key will join us to read the submitted questions aloud.
We have two batches of questions that came in writing. The first is from Tom Mills at Jefferies. His first question: right now there are two high-profile IPO processes underway from two of your European sponsor peers. If those go well, do you see that having a galvanizing effect on the European IPO markets, as well as on sponsor-to-sponsor exit deal flow? Second, those two deals currently in the market are having to deleverage quite materially. Is that something you would also envisage having to do with potential exits, whether sponsor to sponsor or via IPO, to the extent relevant?
Would you like to take that on?
Well, Tom, I think you need to keep in mind that when it comes to the big buyout space, the IPO market is where that action happens. If you look at how large the companies going public tend to be, they're usually in the multi-billion range. So we've completed, well, a very large number — 250 exits across the past 15 years — and only one of those was an IPO. So within Bridgepoint, that's not especially meaningful. That said, yes, I think these offerings are meaningful tests of whether that market opens up this year. There will be consequences for the broader market, since clearly it's what drives the return of capital. And yes, deleveraging matters, because public markets won't tolerate many things, and leverage is one of them.
Moving on to the next question.
And then the second one comes from Nicholas Herman at Citi. This is a technical follow-up question for Adam: could you remind us what the tax rate difference is between fee-related and performance-related earnings at Bridgepoint and ECP? Also, is the tax on net carry negligible, while the tax that is incurred is based on FRE and investment income streams?
Okay, Nicholas, there’s really no simple response to that, and we could easily get tangled up in the technical detail of how those tax liabilities come about and what their relative pieces are. That’s exactly why we have consistently just pointed you toward an effective tax rate of 5%-10% on the Bridgepoint-only elements. And whether you land at the top or bottom of that range is really decided by the exits. So in 2022, we had a big number of exits. The effective tax rate had fallen. All of this relates to the release of deferred tax, and then, with exits slower in 2023, the effective tax rate rises, and we had previously guided to 10%. We came in slightly above 11%. The relative step-up going into 2024, as I mentioned, is entirely driven by the ECP effective tax rate. Clearly that is an offshore payer, though we are looking at whether we can try to find efficiencies there as we go forward. Maybe from a modeling standpoint we can dig into it, but I think we could get ourselves tied in knots. You know, we should probably keep guiding at that 5%-10% for Bridgepoint — that is the right way to think about it.
All right, I believe that brings the questions to a close and wraps up this group of presentations. I hope you found it helpful. If anything comes up, don't hesitate to reach out to Adam Key. With that, many thanks for being with us this morning, and Paulie, thanks for handling the question process.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Bridgepoint Group plc transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Bridgepoint Group plc earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.